Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new history entry (version 51) dated 2026-09-02 was added with a Study Status update. An entry dated 2026-06-23 was removed from the history.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page history shows a revision update from v3.6.5 to v3.6.6. This appears to be an internal page version update and does not modify study data or public details.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedA new revision entry, v3.6.5, has been added to the study record history. The previous revision, v3.6.4, has been removed from the history, reflecting the latest version of the record.SummaryDifference0.1%

- Check56 days agoChange DetectedThe history now includes Revision: v3.6.4, with the previous Revision: v3.6.3 removed. This appears to be a minor revision to the page history rather than an update to study data.SummaryDifference0.1%

- Check70 days agoChange DetectedThe Record History view now displays an expanded sequence of past versions and release-note style entries, and the footer/navigation has been updated to include additional links and site information.SummaryDifference77%

- Check77 days agoChange DetectedThe latest version of the study history page removes the site footer and associated navigation/release-notes elements, resulting in a cleaner, more minimal layout.SummaryDifference17%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.